« Previous article
HiPetriSlim™: ...

22nd April 2024  Content supplied by: Himedia Laboratories Pvt. Ltd

HiMedia's Molecular Solutions for Detection of Antimicrobial Resistance

AMR detection by traditional method is laborious and has other limitations in terms of time, assay sensitivity and quantification. Molecular diagnostics not only helps in rapid detection, but also provides the most sensitive and accurate data required to decide the further line of treatment. We provide a one-stop solution for clinical diagnostics with the most versatile instruments, such as InstaNX® Mag automated extractors and the InstaQ series of thermal cyclers, extraction & PCR kits, and consumables.HiGenoMB® has a complete portfolio of accurate and sensitive Real-time PCR Kits for Clinical diagnostics that covers

  • Acute Febrile Illness including Dengue, Chikungunya, etc.
  • Respiratory Panel
  • Antimicrobial Resistance (AMR)
  • Genetic Disorders and
  • Common pathogens such as E. coli, viruses.

The AMR panel includes CE/IVD approved kits for the most prevalent drug resistance observed clinically in both gram-negative as well as gram-positive bacteria, such as:

  • Extended Spectrum Beta Lactamases (ESBLs)
  • Carbapenemase
  • Colistin resistance
  • Vancomycin-resistant Enterococci
  • Methicillin-Resistant Staphylococcus aureus

Each Multiplex Kit (single or two-tube assay) is designed to detect all predominant mutations contributing to resistance. Clinical samples, including blood and tissues, are subjected to automated extraction followed by qPCR to yield the most sensitive results within 2-3 hours. Quantitative assays help the doctor prescribe antibiotics accordingly.

The Hi-Gx360® Sequencing and Bioinformatics platform allows a person to determine the type of AMR using Next Generation Sequencing (NGS), which is a gold standard, combined with cutting-edge Bioinformatic analysis providing the most accurate results within a stipulated time period.

To find out more, download the HiMedia AMR Molecular Diagnostics Catalogue. Learn about the complete range of HiGenoMB’s solutions for clinical diagnostics here, or use the Request Information button below to contact the supplier directly.

Share on:


Date Published: 22nd April 2024

Source article link: View

View full company details